Kohl's Urged to Consider Sale by Activist Investor 
 

Activist Engine Capital sent a letter also pressing the department-store chain to consider a separation of its e-commerce business.


 
Nvidia's Deal Setback Eased by Soaring Chip Demand 
 

The FTC has sued to block Nvidia's proposed takeover of Arm Holdings. But analysts say exploding growth in semiconductor demand is expected to ease the setback facing the chip maker if it can't complete the deal.


 
Cruise Pricing Risks Sailing Off the Deep End 
 

Cruise pricing has never been a better deal for consumers in some cases. But cruise companies can't afford for that dynamic to last.


 
CNN President Jeff Zucker Protected Chris Cuomo. Then Came a U-Turn. 
 

The network boss fired the star anchor on Saturday, leaving a hole in the channel's prime-time lineup.


 
California Dairy Farmers Struggle to Stay in the 'Got Milk' State 
 

Recurring droughts add to challenges in the nation's top milk producer, causing farmers to move, close or turn to growing crops. "We're scared to death we'll have one more dry year."


 
Spotify Removes Some Comedians' Work From Streaming Service 
 

A push for royalty payments on comedic material has sidelined the work of Jim Gaffigan, John Mulaney and hundreds of other comedians on Spotify.


 
Noodles Restaurant Chain Bets on Costlier Cheesy Pasta 
 

Colorado-based Noodles & Co. and other U.S. restaurant chains are weighing consumers' willingness to spend more on food as prices for goods rise.


 
Boral to Sell North American Fly Ash Unit 
 

Boral Ltd. will sell its North American fly ash business for $755 million to Eco Material Technologies Inc., as part of its strategic overhaul to refocus on Australia's construction materials sector.


 
U.K. Digital-Health Startup Vinehealth Raises Seed Financing 
 

Vinehealth Digital uses its technology to help drugmakers better understand cancer patients' experience with their medications.


 
Lilly's Covid-19 Antibody Treatment Authorized for Use in Children 
 

The FDA's authorization expands the drug's use to fight Covid-19 to people under the age of 12.

(END) Dow Jones Newswires

12-05-21 2115ET